secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexentis Technologies Inc. (NXTS)
CIK:        0001789192
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001493152-25-010502
Event type: debt
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

N2OFF loans $250K to MitoCareX, pending acquisition funding
-----------------------------------------------------------

- $250,000 loan to MitoCareX Bio Ltd., 6-month term, interest at Israel tax rate + 3%.
- Loan guaranteed by L.I.A. Pure Capital Ltd.
- Second $250K loan to MitoCareX; prior loan dated Dec 22, 2024.
- Loan intended to cover MitoCareX costs until closing of Feb 2025 acquisition agreement.
- If acquisition closes, outstanding loan amount deducted from first-year allocation to MitoCareX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789192/000149315225010502/0001493152-25-010502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789192/000149315225010502/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-010502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer